With the help of an electron microscope so sensitive it had to be buried in tons of concrete to prevent vibrations, School of Medicine researcher Edward H. Egelman has finally unlocked the elusive structure of the bamboo mosaic virus.

Strange rings of DNA that exist outside chromosomes are distinct to the cell types that mistakenly produced them, researchers have discovered. The finding raises the possibility that the rings could be used as an indicator of different types of cancer.

The U.Va. School of Medicine and the U.S. Green Building Council have been awarded a three year, $1.2 million grant from the Robert Wood Johnson Foundation to advance their Green Health Partnership.

A U.Va. study finds nearly a third of women in Appalachian regions of Kentucky, Ohio, North Carolina and Pennsylvania fail to follow through with therapy medication prescribed to prevent breast cancer’s recurrence.

One virus suspected in the national outbreak has only been linked to a handful of cases, but a U.Va. physician is pointing toward another for which no one else may have tested.

Atherosclerosis – best known as hardening of the arteries – is the leading cause of death worldwide. A new study finds that researchers knew less about the disease than they thought, but suggests a possible new avenue for treatment.

An international team led by U.Va.’s Lukas Tamm will look at changes in the virus’s outer envelope as it adapts to different hosts, with an eye toward predicting possible pandemics.

New laboratory technology that gives doctors the power to examine patients’ DNA quickly and effectively represents “a big step forward for the institution and the patients who come here,” director of the lab Dr. Mani S. Mahadevan said.

Doctors stress that the treatment is not a cure for patients with a rare form of leukemia, but can buy time for patients as they seek stem cell donors. It’s also an approach that could be used against other cancers, they said.

As potential new stem-cell treatments for blindness caused by diabetic retinopathy advance toward trials, the research team answered one key question: Where should the stem cells come from?